NCT07845487: A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- State
- Under way
- Phase
- Phase 2
- People
- 204 planned
- Started
- 28 Aug 2026
- Primary completion
- Oct 2027
- Arms
- PALI-2108 Dose 1, PALI-2108 Dose 2
- Results
- None posted
- 28 Aug 2026: Trial started
- 29 Sep 2026: Trial registered